Americans will be flocking to the Caribbean for their yearly getaway. Be it the tropical atmosphere, regardless of season, or ...
Immuneering plans to evaluate IMM-1-104 in combination with Libtayo in patients with advanced non-small cell lung cancer in its ongoing Phase 2a trial - - Data presented at AACR 2023 supports ...